The Academy of Physicians in Clinical Research Board of Trustees has the responsibility to support the organization’s mission and vision, serve as strategic decision-makers, and holds the legal authority of its organization. The Board governs the objectives and purposes of APCR which include (i) enhancing further the organization’s value proposition to its members through advocacy, competency and exchange, (ii) representing physicians directly or indirectly involved in clinical research endeavors, (iii) enhancing the proficiency of physicians directly or indirectly involved in clinical research endeavors, (iv) promoting the acquisition and dissemination of knowledge concerning therapeutic action, investigation, and development of pharmaceuticals, biologics, medical devices, and diagnostics, and (v) protecting the welfare of patients and study subjects. Trustees are elected from the APCR membership and the ACRP Nominating Committee is charged, by the APCR Board, with leading the recruitment process for qualified candidates.
Lyndon Mansfield, MD, FAPCR, CPI
Dr. Mansfield is a Certified Principal Investigator and is also Board Certified in Allergy/Immunology, Diagnostic Clinical Laboratory Immunology and Pediatrics. He has been involved in clinical research for over 30 years. Most of this research was on Asthma, COPD, Rhinitis, Urticaria, Atopic Dermatitis and Food Allergy. He has participated in over 312 clinical research protocols, has authored or co-authored over 100 medical manuscripts and over 115 scientific research presentations.
IMMEDIATE PAST PRESIDENT
Cara East, MD, FAPCR
Dr. East has been involved in clinical trial research since 1987, working as a principal investigator for over 70 trials. She has also participated as a subinvestigator in more than 20 trials. Such studies have included the use of stem cells in cardiomyopathy and as an adjunct to heart surgery, studies of renal artery nerve ablation as an alternative treatment for hypertension, the use of mipomersen and the PCSK9 inhibitors in familial hypercholesterolemia, the development of novel oral anticoagulants for the prevention of thromboembolic events in atrial fibrillation, the need for repeat ablation following cryoablation for atrial fibrillation, and the gender of authors in a local journal. She has over 48 articles published in peer-reviewed journals and serves as a reviewer for several journals. She is currently a clinical professor at Texas A&M College of Medicine and a cardiology staff attending for Baylor University Medical Center Internal Medicine teaching program. She served on a general medicine IRB and as the cardiologist on an oncology IRB. She currently is a National Leader of the Paradise trial and is the chairman of the Data Safety Monitoring Committee for the NIH trial “Exercise and intensive vascular risk reduction in preventing dementia.”
Harry Sarles, MD, FAPCR
Harry E. Sarles, Jr., MD, FACG, is a graduate of the University of Texas, Medical Branch, at Galveston. He has trained in Internal Medicine and Gastroenterology at the University of Texas, Medical Branch, at Galveston, and the Veterans Administration (VA) Hospital, Phoenix, Arizona through the University of Arizona. Dr. Sarles obtained Board Certification from the American Board of Internal Medicine in January 1983 and Board Certification from the American Board of Internal Medicine, Subspecialty of Gastroenterology in January 1985. He has been practicing medicine for the past 27 years at Digestive Health Associates of Texas, PA (DHAT), where he delivers care to his patients. He is Vice President of his group and conducts clinical research as the Principal Investigator, and Medical Director of the DHAT Research Institute since March 2016. He was appointed to the Board of American College of Gastroenterology Institute for Research and Education in 2015. He currently gives oversight and serves as principal investigator for clinical research trials in the broader fields of Gastroenterology and Hepatology. Dr. Sarles is affiliated with the American Gastroenterology Association (AGA), the American Society of Gastrointestinal Endoscopy (ASGE), the Texas Society of Gastroenterology (TSGE), and a Fellow of the American College of Gastroenterology (FACG). Dr. Sarles is well spoken, published, and dedicated. He is the 2005 recipient of the Texas Society for Gastroenterology and Endoscopy Marcel Patterson /Robert Nelson Career Service Award, and the recipient of the American College of Gastroenterology William D. Carey, MD Board of Governors College Leadership Award. He is a past president of the American College of gastroenterology and Texas Society for gastroenterology and Endoscopy.
Ricardo Correa Marquez, MD, Es.D, FAPCR
Dr. Correa received his Medical Doctor degree from the University of Panama and his Masters on Education from the University of Panama. He did his Internal Medicine residency at University of Miami-Jackson Memorial Hospital and Endocrinology, diabetes and metabolism fellowship at the National Institute of Health.
Peter Rheinstein, MD, JD, FAPCR
Dr. Rheinstein is a board-certified physician and licensed attorney. Dr. Rheinstein is currently Chairman of both the USAN Council, which assigns the generic names for all drugs marketed in the US, and the American Board of Legal Medicine, which is the certifying body for physician attorneys claiming special knowledge of medical law. He is President of the Academy of Medicine of Washington, DC. He currently serves on the Boards of the American College of Legal Medicine, Intercultural Friends Foundation and Collington Continuing Care Retirement Community. He serves in the American Medical Association House of Delegates and the US Pharmacopeial Convention. He is a Past President of both the Academy of Physicians in Clinical Research and the Drug Information Association. He publishes Discovery Medicine, an internet based medical journal.
Under vote for membership approval
Peter Rheinstein, MD, JD, MS, FAPCR
Michael Ybarra, MD, FAPCR